Targeted Inhibition of CHD1L by OTI-611 Reprograms Chemotherapy and Targeted Therapy-Induced Cell Cycle Arrest and Suppresses Proliferation to Produce Synergistic Antitumor Effects in Breast and Colorectal CancerCELLSIF5.22025-02-200OAAI
TNBC cell co-culture with primary human lung fibroblasts identifies a paracrine-juxtacrine signaling loop promoting fibroblast activation and autophagydependent breast cancer cell therapy resistanceCANCER RESEARCHIF16.62024-04-050PRE
The validation of new CHD1L inhibitors as a therapeutic strategy for cancerBIOMEDICINE & PHARMACOTHERAPYIF7.52024-01-010OAAI
Oxidative stress as a candidate mechanism for accelerated neuroectodermal differentiation due to trisomy 21FREE RADICAL BIOLOGY AND MEDICINEIF8.22022-06-018OAAI
Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1LJOURNAL OF MEDICINAL CHEMISTRYIF6.82022-02-2210OA
Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancerONCOGENEIF7.32021-03-1916OAAI
First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal CancerMOLECULAR CANCER THERAPEUTICSIF5.52020-08-0430OAAI
Drug Design Targeting T-Cell Factor-Driven Epithelial-Mesenchymal Transition as a Therapeutic Strategy for Colorectal CancerJOURNAL OF MEDICINAL CHEMISTRYIF6.82019-11-0114OAAI
Glycolytic and redox control of neuronal excitability in vitro体外神经元兴奋性的糖酵解和氧化还原控制FREE RADICAL BIOLOGY AND MEDICINEIF8.22018-11-010PREAI
Mitochondrial-Localized Versus Cytosolic Intracellular CO-Releasing Organic PhotoCORMs: Evaluation of CO Effects Using BioenergeticsACS CHEMICAL BIOLOGYIF3.82018-06-2244OA
Sense and Release: A Thiol-Responsive Flavonol-Based Photonically Driven Carbon Monoxide-Releasing Molecule That Operates via a Multiple-Input AND Logic GateJOURNAL OF THE AMERICAN CHEMICAL SOCIETYIF15.62017-07-05119PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向